吴鸿明, 隋海晶. 胸部低剂量螺旋CT检查用于无症状成人肺癌筛查效果[J]. 中国辐射卫生, 2023, 32(2): 176-181.
WU Hongming, SUI Haijing. Effect of chest low-dose spiral CT scan for lung cancer screening among asymptomatic adults. Chinese Journal of Radiological Health, 2023, 32(2): 176-181.
[1] Mohindra NA, Patel JD. Top advances in lung cancer, 2021[J]. Cancer, 2022, 128(19): 3434-3437. DOI: 10.1002/cncr.34406 [2] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660 [3] Zhang JR, Li JF, Xiong S, et al. Global burden of lung cancer: implications from current evidence[J]. Ann Cancer Epidemiol, 2021, 5: 4. DOI: 10.21037/ace-20-31 [4] Ning J, Ge T, Jiang ML, et al. Early diagnosis of lung cancer: which is the optimal choice?[J]. Aging, 2021, 13(4): 6214-6227. DOI: 10.18632/aging.202504 [5] Cainap C, Pop LA, Balacescu O, et al. Early diagnosis and screening in lung cancer[J]. Am J Cancer Res, 2020, 10(7): 1993-2009 [6] Seijo LM, Peled N, Ajona D, et al. Biomarkers in lung cancer screening: Achievements, promises, and challenges[J]. J Thorac Oncol, 2019, 14(3): 343-357. DOI: 10.1016/j.jtho.2018.11.023 [7] Tammemagi MC, Lam S. Screening for lung cancer using low dose computed tomography[J]. BMJ, 2014, 348: g2253. DOI: 10.1136/bmj.g2253 [8] Xiang D, Zhang BC, Doll D, et al. Lung cancer screening: from imaging to biomarker[J]. Biomark Res, 2013, 1(1): 4. DOI: 10.1186/2050-7771-1-4 [9] El-Bayoumi E, Silvestri GA. Bronchoscopy for the diagnosis and staging of lung cancer[J]. Semin Respir Crit Care Med, 2008, 29(3): 261-270. DOI: 10.1055/s-2008-1076746 [10] Mascaux C, Peled N, Garg K, et al. Early detection and screening of lung cancer[J]. Expert Rev Mol Diagn, 2010, 10(6): 799-815. DOI: 10.1586/erm.10.60 [11] Li W, Liu JB, Hou LK, et al. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring[J]. Mol Cancer, 2022, 21(1): 25. DOI: 10.1186/s12943-022-01505-z [12] Pisapia P, Malapelle U, Troncone G. Liquid biopsy and lung cancer[J]. Acta Cytol, 2019, 63(6): 489-496. DOI: 10.1159/000492710 [13] Guibert N, Pradines A, Favre G, et al. Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages[J]. Eur Respir Rev, 2020, 29(155): 190052. DOI: 10.1183/16000617.0052-2019 [14] Zhang K, Chen KZ. Artificial intelligence: opportunities in lung cancer[J]. Curr Opin Oncol, 2022, 34(1): 44-53. DOI: 10.1097/CCO.0000000000000796 [15] Ardila D, Kiraly AP, Bharadwaj S, et al. End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography[J]. Nat Med, 2019, 25(6): 954-961. DOI: 10.1038/s41591-019-0447-x [16] Avanzo M, Stancanello J, Pirrone G, et al. Radiomics and deep learning in lung cancer[J]. Strahlenther Onkol, 2020, 196(10): 879-887. DOI: 10.1007/s00066-020-01625-9 [17] Wisnivesky JP, Mushlin AI, Sicherman N, et al. The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening[J]. Chest, 2003, 124(2): 614-621. DOI: 10.1378/chest.124.2.614 [18] Oudkerk M, Liu SY, Heuvelmans MA, et al. Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives[J]. Nat Rev Clin Oncol, 2021, 18(3): 135-151. DOI: 10.1038/s41571-020-00432-6 [19] Yuan JM, Sun Y, Wang K, et al. Cost effectiveness of lung cancer screening with low-dose CT in heavy smokers in China[J]. Cancer Prev Res (Phila), 2022, 15(1): 37-44. DOI: 10.1158/1940-6207.CAPR-21-0155 [20] Azar FE, Azami-Aghdash S, Pournaghi-Azar F, et al. Cost-effectiveness of lung cancer screening and treatment methods: a systematic review of systematic reviews[J]. BMC Health Serv Res, 2017, 17(1): 413. DOI: 10.1186/s12913-017-2374-1 [21] Lam S. Lung cancer screening in never-smokers[J]. J Thorac Oncol, 2019, 14(3): 336-337. DOI: 10.1016/j.jtho.2018.12.019 [22] Wood DE. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Lung Cancer Screening[J]. Thorac Surg Clin, 2015, 25(2): 185-197. DOI: 10.1016/j.thorsurg.2014.12.003 [23] Godoy MCB, Odisio EGLC, Erasmus JJ, et al. Understanding Lung-RADS 1.0: A case-based review[J]. Semin Ultrasound CT MRI, 2018, 39(3): 260-272. DOI: 10.1053/j.sult.2018.03.001 [24] Matos Figueroa JR, Vázquez Torres OL, Hernández I, et al. PET-CT scan positive pulmonary nodule revealing histoplasmosis: a case report[J]. Bol Asoc Med P R, 2010, 102(4): 47-50 [25] Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer[J]. J Thorac Oncol, 2016, 11(1): 39-51. DOI: 10.1016/j.jtho.2015.09.009 [26] Jonas DE, Reuland DS, Reddy SM, et al. Screening for lung cancer with low-dose computed tomography: Updated evidence report and systematic review for the US Preventive Services Task Force[J]. JAMA, 2021, 325(10): 971-987. DOI: 10.1001/jama.2021.0377 [27] 唐威, 吴宁, 黄遥, 等. 4690例无症状健康体检者低剂量CT早期肺癌筛查研究[J]. 中华肿瘤杂志,2014,36(7):549-554. DOI: 10.3760/cma.j.issn.0253-3766.2014.07.016 Tang W, Wu N, Huang Y, et al. Results of low-dose computed tomography (LDCT)screening for early lung cancer: prevalence in 4 690 asymptomatic participants[J]. Chin J Oncol, 2014, 36(7): 549-554. DOI: 10.3760/cma.j.issn.0253-3766.2014.07.016 [28] 张勇, 洪群英, 施伟斌, 等. 低剂量螺旋CT在肺癌筛查中的应用价值[J]. 中华医学杂志,2013,93(38):3011-3014. DOI: 10.3760/cma.j.issn.0376-2491.2013.38.002 Zhang Y, Hong QY, Shi WB, et al. Value of low-dose spiral computed tomography in lung cancer screening[J]. Nat Med J China, 2013, 93(38): 3011-3014. DOI: 10.3760/cma.j.issn.0376-2491.2013.38.002 [29] 谢欣, 许慧琳, 严玉洁, 等. 低剂量螺旋CT对7496名社区肺癌高危人群的筛查研究[J]. 中国肿瘤,2015,24(10):811-814. DOI: 10.11735/j.issn.1004-0242.2015.10.A002 Xie X, Xu HL, Yan YJ, et al. Lung cancer screening using low-dose computed tomography in 7496 community residents with high-risk[J]. Chin Cancer, 2015, 24(10): 811-814. DOI: 10.11735/j.issn.1004-0242.2015.10.A002 [30] Bonney A, Malouf R, Marchal C, et al. Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality[J]. Cochrane Database Syst Rev, 2022, 8(8): CD013829. DOI: 10.1002/14651858.CD013829.pub2
